JPS5282721A - Production of chcken poxx herpes zoster virus vaccine - Google Patents

Production of chcken poxx herpes zoster virus vaccine

Info

Publication number
JPS5282721A
JPS5282721A JP15733876A JP15733876A JPS5282721A JP S5282721 A JPS5282721 A JP S5282721A JP 15733876 A JP15733876 A JP 15733876A JP 15733876 A JP15733876 A JP 15733876A JP S5282721 A JPS5282721 A JP S5282721A
Authority
JP
Japan
Prior art keywords
poxx
chcken
production
virus vaccine
zoster virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15733876A
Other languages
English (en)
Japanese (ja)
Other versions
JPS624370B2 (OSRAM
Inventor
Jito Jiyakurin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIT RECH IND THERAPEUT
Original Assignee
RIT RECH IND THERAPEUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIT RECH IND THERAPEUT filed Critical RIT RECH IND THERAPEUT
Publication of JPS5282721A publication Critical patent/JPS5282721A/ja
Publication of JPS624370B2 publication Critical patent/JPS624370B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP15733876A 1975-12-29 1976-12-24 Production of chcken poxx herpes zoster virus vaccine Granted JPS5282721A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/644,787 US4008317A (en) 1975-12-29 1975-12-29 Varicella-zoster virus vaccine and preparation thereof

Publications (2)

Publication Number Publication Date
JPS5282721A true JPS5282721A (en) 1977-07-11
JPS624370B2 JPS624370B2 (OSRAM) 1987-01-30

Family

ID=24586321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15733876A Granted JPS5282721A (en) 1975-12-29 1976-12-24 Production of chcken poxx herpes zoster virus vaccine

Country Status (6)

Country Link
US (1) US4008317A (OSRAM)
JP (1) JPS5282721A (OSRAM)
BE (1) BE849897A (OSRAM)
DE (1) DE2655691C2 (OSRAM)
FR (1) FR2336944A1 (OSRAM)
GB (1) GB1565830A (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
US4714678A (en) * 1982-10-13 1987-12-22 Smithkline-Rit Temperature sensitive strain of bovine viral diarrhoea virus
IT1213254B (it) * 1984-12-06 1989-12-14 Boehringer Biochemia Srl Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
ES2150906T3 (es) 1990-10-04 2000-12-16 Res Corp Technologies Inc Antigeno del virus varicella-zoster.
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
JP4562812B2 (ja) * 1992-07-17 2010-10-13 メルク・シャープ・エンド・ドーム・コーポレイション 帯状疱疹の予防または水痘関連ヘルペス後神経痛の緩和方法
US5879675A (en) * 1994-03-15 1999-03-09 Medical College Of Pennsylvania And Hahnemann University Compositions and methods for vaccines comprising α-galactosyl epitopes
US7666082B2 (en) * 2004-05-07 2010-02-23 Gamelogic Inc. Method and apparatus for conducting a game of chance
US10350289B2 (en) 2013-09-05 2019-07-16 Merck Sharp & Dohme Corp. Methods of immunization with varicella zoster virus antigen

Also Published As

Publication number Publication date
US4008317A (en) 1977-02-15
GB1565830A (en) 1980-04-23
FR2336944B1 (OSRAM) 1980-07-18
FR2336944A1 (fr) 1977-07-29
BE849897A (fr) 1977-06-28
DE2655691C2 (de) 1985-08-14
JPS624370B2 (OSRAM) 1987-01-30
DE2655691A1 (de) 1977-07-14

Similar Documents

Publication Publication Date Title
GR60854B (en) Preparation process of benzylidenic derivatives
GR62109B (en) Preparation process of quinazolone derivatives
GR59797B (en) Preparation process of thieno-pyridine derivatives
GR60835B (en) Preparation process of delta15-steroids
GR59482B (en) Preparation process of novel biphenyloxy-derivatives
GR60435B (en) Preparation process of acylamino-derivatives
JPS5282721A (en) Production of chcken poxx herpes zoster virus vaccine
GR59280B (en) Process for the preparation of 1-aryloxy-3-n-substituted aminopropane derivatives
JPS51136772A (en) Preparation of high ciss1*44polybutadiene
JPS51133414A (en) Production of vaccine against viral hepatisis
GR60047B (en) Preparation process of 11-desoxy-16-aryloxy-omega-tetranorprostaglandins
JPS5212924A (en) Production of virus pesticidal comrosition
JPS51115427A (en) Preparation of ethylbenzole
JPS51131836A (en) Preparation of acetoacetylarylamide
JPS5251330A (en) Preparation of trichloromethyll trifluoromethyllbenzene
GR60849B (en) Preparation process of l-pyroglutamyl-l-prolinamide
GR60822B (en) Preparation process of novel homophthalimides
IL51013A (en) Production of ethyl chloro-thioformate
IL50323A (en) Process for the preparation of s-substituted phosphoro-dichloridothiolates
PT65459B (en) Process of preparation of pyrroline derivatives
GB1539733A (en) Preparation of 3-phenoxybenzaldehydes
JPS5259118A (en) Preparation of trichloromethyll trifluoromethyllbenzene
JPS5231825A (en) Identification of virus
IL50634A0 (en) Preparation of 2-amino-1-alcohols
PT65624B (en) Process of preparation of 4-hydroxymethyl-2-pyrrolidinones